In addition, in vitro application of APX2009 to dorsal root ganglia and IP injection of APX3330 for IBD resulted in neuronal protection, demonstrating that APE1/Ref-1 inhibitors are not only not systemically toxic, but are also beneficial and protective [45,91]. The gene discussed is APEX1; the disease is inflammatory bowel disease.